Evaluation of N-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors

J Enzyme Inhib Med Chem. 2024 Dec;39(1):2286935. doi: 10.1080/14756366.2023.2286935. Epub 2023 Dec 7.

Abstract

Two series of N-alkyl isatins and N-alkyl indoles varying in size of the alkyl group were synthesised and evaluated for inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among the N-alkyl isatins 4a-j, the addition of the N-alkyl group improved inhibition potency towards AChE and BChE compared to isatin. Selectivity towards inhibition of BChE was observed, and the increase in size of the N-alkyl group positively correlated to improved inhibition potency. The most potent inhibitor for BChE was 4i (IC50 = 3.77 µM, 22-fold selectivity for BChE over AChE). N-alkyl indoles 5a-j showed similar inhibition of AChE, the most potent being 5g (IC50 = 35.0 µM), but 5a-j lost activity towards BChE. This suggests an important role of the 3-oxo group on isatin for BChE inhibition, and molecular docking of 4i with human BChE indicates a key hydrogen bond between this group and Ser198 and His438 of the BChE catalytic triad.

Keywords: Isatin; acetylcholinesterase; butyrylcholinesterase; indole.

MeSH terms

  • Acetylcholinesterase* / metabolism
  • Butyrylcholinesterase / metabolism
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology
  • Humans
  • Indoles / pharmacology
  • Isatin* / pharmacology
  • Molecular Docking Simulation
  • Structure-Activity Relationship

Substances

  • Acetylcholinesterase
  • Butyrylcholinesterase
  • Isatin
  • Indoles
  • Cholinesterase Inhibitors